Triiodothyronine does not increase osteogenic differentiation reduced by age in bone marrow mesenchymal stem cells of female rats;Triiodotironina não aumenta a diferenciação osteogênica reduzida pela idade de célulastronco mesenquimais da medula óssea de ratas

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 57, Issue 1, 2013, Pages 62-70

  Boeloni, Jankerle Neves ^a   Ocarino, Natalia Melo ^a   Goes, Alfredo Miranda ^a   Serakides, Rogéria ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bone marrow; Female rats; Mesenchymal stem cells; Osteogenic differentiation; Triiodothyronine

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN; LIOTHYRONINE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; PHENOTYPE; RAT; WISTAR RAT;

ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW CELLS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; FEMALE; MESENCHYMAL STROMAL CELLS; MODELS, ANIMAL; OSTEOGENESIS; PHENOTYPE; RATS; RATS, WISTAR; TETRAZOLIUM SALTS; THIAZOLES; TRIIODOTHYRONINE;

EID: 84874526523     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302013000100009     Document Type: Article

References (35)

1. Hughes FJ, Turner W, Belibasakis G, Martuscelli G. Effects of growth factors and cytokines on osteoblast differentiation. Periodontology 2000. 2006;41:48-72.
2. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol. 2006;44:215-30.
3. Payushina OV, Domaratskaya EI, Starostin VI. Mesenchymal stem cells: sources, phenotype, and differentiation potential. Cell Biol. 2006;33:2-18.
4. Ocarino NM, Marubayashi U, Cardoso TGS, Guimarães CV, Silva AE, Torres RC, et al. Physical activity in osteopenia treatment improved the mass of bones directly and indirectly submitted to mechanical impact. J Musculoskelet Neuronal Interact. 2007;7:84-93.
5. Fromigué O, Marie PJ, Lomri A. Differential effects of transforming growth factor b2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine. 1997;9:613-23.
6. Thomas T, Gori F, Khosla S, Jensen MD, Burquera B, Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology. 1999;140:1630-8.
7. Hong L, Colpan A, Peptan IA. Modulations of 17-b estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells. Tissue Eng. 2006;12:2747-53.
8. Boeloni JN, Ocarino NM, Melo AB, Silva JF, Castanheira P, Goes AM, et al. Dose-dependent effects of triiodothyronine on osteogenic differentiation of rat bone marrow mesenchymal stem cells. Horm Res. 2009;71:88-97.
9. Hong L, Sultana H, Paulius K, Zhang G. Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference. J Steroid Biochem Mol Biol. 2009;114:180-5.
10. Hell RCR, Boeloni JN, Ocarino NM, Silva JF, Goes AM, Serakides R. Efeito da triiodotironina na expressão das proteínas ósseas durante a diferenciação osteogênica de células-tronco mesenquimais. Arq Bras Endocrinol Metab. 2011;55:339-44.
11. Mueller SM, Glowacki J. Age-Related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem. 2001;82:583-90.
12. Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong TH, Zhou G, et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol. 2008;9:1-13.
13. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res. 2008;314:1937-44.
14. Zhang W, Ou G, Hamrick M, Hill W, Borke J, Wenger K, et al. Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J Bone Miner Res. 2008;23:1118-28.
15. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS, et al. Age-related intrinsic changes in human bone-marrow derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7:335-43.
16. Ocarino NM, Boeloni JN, Goes AM, Silva JF, Marubayashi U, Serakides R. Osteogenic differentiation of mesenchymal stem cells from osteopenic rats subjected to physical activity with and without nitric oxide synthase inhibition. Nitric Oxide. 2008;19:320-5.
17. Boeloni JN. Efeitos in vivo e in vitro dos hormônios tireoidianos na diferenciação osteogênica de células-tronco mesenquimais da medula óssea e do tecido adiposo de ratas ovariectomizadas e não ovariectomizadas. (Tese de doutorado em Ciência Animal). Belo Horizonte, Escola de Veterinária, UFMG, 2012. p. 266.
18. Hell RCR, Ocarino NM, Boeloni JN, Silva, JF, Goes AM, Santos RL, et al. Physical activity improves age-related decline in the osteogenic potential of rats' bone marrow-derived mesenchymal stem cells. Acta Physiol (Oxf). Acta Physiol (Oxf). 2012;205(2):292-301.
19. Lee HS, Huang GT, Chiang H, Chiou LL, Chen MH, Hsieh CH, et al. Multipotencial mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells. 2003;21:190-9.
20. Tropel P, Noël D, Platet N, Legrand P, Benabid AL, Berger F. Isolation and characterization of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res. 2004;295:395-406.
21. Nadri S, Soleimani M, Hosseni RH, Massumi M, Atashi A, Izadpanah R. An efficient method of isolation of murine bone marrow mesenchymal stem cells. Int J Dev Bio. 2007;51:723-9.
22. Ishii M, Koike C, Igarashi A, Yamanaka K, Pan H, Higashi Y, et al. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Commun. 2005a;332:297-303.
23. Ishida H, Bellows CG, Aubin JE, Heersche JN. Tri-iodothyronine (T3) and dexamethasone interact to modulate osteoprogenitor cell differentiation in fetal rat calvaria cell cultures. Bone. 1995;16:545-9.
24. Prophet EB, Mills B, Arrington JB, Sobin LH. Laboratory Methods in Histotechnology. Washington DC: Armed Forces Institute of Pathology; 1992. p. 278.
25. Sampaio IBM. Estatística aplicada à experimentação animal. Belo Horizonte: FEP/MVZ; 1998. p. 211.
26. Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
27. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989;119:203-10.
28. Smejkal GB, Kaul CA. Stability of nitroblue tetrazolium-based alkaline phosphatase substrates. J Histochem Cytochem. 2001;49:1189-90.
29. Bianco P, Riminucci SG, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19:180-92.
30. Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells. 2005b;23:699-706.
31. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-7.
32. Covas DT, Siufi JLC, Silva ARL, Orellana MD. Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res. 2003;36:1179-83.
33. Tocci A, Forte L. Mesenchymal stem cells: use and perspectives. Hematol J. 2003;4:92-6.
34. Schäffler A, Büchler C. Concise review: adipose tissue-derived stromal cells basic and clinical implications for novel cell-based therapies. Stem Cells. 2007;25:818-27.
35. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs Jr DR, Lee D-H, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews. 2012 (no prelo). Arq Bras Endocrinol Metab. 2013;57/1